Alkem Laboratories Shareholders Meeting on Aug 17 for Amalgamation Scheme

Alkem Laboratories Limited has announced that a meeting of its equity shareholders will be convened on August 17, 2026, at 11:00 a.m. IST, through electronic mode (video conference or other audio-visual means). This meeting is being held pursuant to an order from the National Company Law Tribunal (NCLT), Mumbai Bench, dated June 10, 2026. The purpose of the meeting is to consider and, if thought fit, approve the Scheme of Amalgamation between Alkem Laboratories Limited and Adroit Biomed Limited. The NCLT has dispensed with the need for separate meetings of secured and unsecured creditors of Alkem Laboratories Limited for this scheme. The notice of this meeting, along with the Scheme and an explanatory statement, was dispatched to equity shareholders on July 15, 2026. These documents are also available on the company's website, www.alkemlabs.com, and the websites of BSE and NSE. The NCLT has appointed Mr. Harihar Prakash Chaturvedi as the Chairperson for this meeting. Equity shareholders entitled to attend and vote can do so through remote e-voting prior to the meeting or via e-voting during the meeting. The cut-off date for determining entitlement to vote is August 10, 2026. The results of the voting will be announced within two working days of the meeting's conclusion.